Jennison Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-66,234
| Closed | -$27.6M | – | 581 |
|
|
2022
Q3 | $27.6M | Buy |
66,234
+1,399
| +2% | +$584K | 0.03% | 271 |
|
|
2022
Q2 | $32.1M | Sell |
64,835
-3,026
| -4% | -$1.5M | 0.03% | 238 |
|
|
2022
Q1 | $38.2M | Buy |
67,861
+15,638
| +30% | +$8.81M | 0.03% | 260 |
|
|
2021
Q4 | $39.5M | Buy |
52,223
+41
| +0.1% | +$31K | 0.03% | 262 |
|
|
2021
Q3 | $38.9M | Buy |
52,182
+22,922
| +78% | +$17.1M | 0.03% | 254 |
|
|
2021
Q2 | $18.9M | Buy |
29,260
+7,402
| +34% | +$4.77M | 0.01% | 376 |
|
|
2021
Q1 | $12.5M | Buy |
21,858
+6,975
| +47% | +$3.98M | 0.01% | 403 |
|
|
2020
Q4 | $8.68M | Buy |
14,883
+5,278
| +55% | +$3.08M | 0.01% | 415 |
|
|
2020
Q3 | $4.95M | Buy |
9,605
+3,361
| +54% | +$1.73M | ﹤0.01% | 435 |
|
|
2020
Q2 | $2.82M | Buy |
6,244
+4,329
| +226% | +$1.95M | ﹤0.01% | 451 |
|
|
2020
Q1 | $671K | Buy |
+1,915
| New | +$671K | ﹤0.01% | 521 |
|